Skip to main content
Signal8

STEPHENSON BRIAN C

SEC insider (Form 3/4/5 filer). CIK 0001780030. Chief Financial Officer at Faeth Therapeutics, Inc. (FTH) and 1 other issuer. 34 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in AUSTIN, TX.

Companies STEPHENSON BRIAN C has filed insider reports for

  • Faeth Therapeutics, Inc. (FTH): Officer, Chief Financial Officer
  • BridgeBio Pharma, Inc. (BBIO): Officer, Secretary, Treasurer & CFO
STEPHENSON BRIAN C profile photo

STEPHENSON BRIAN C

CIK: 0001780030

Transaction Breakdown

Open Market Buys (P)22 (64.7%)

High conviction signal

Open Market Sales (S)5 (14.7%)

Position reduction

Option Exercises (M)4 (11.8%)

Derivative conversions

Awards (A)1 (2.9%)

Compensation grants

Other (G, F, J, C, D, …)2 (5.9%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Faeth Therapeutics, Inc. logo
FTH

Faeth Therapeutics, Inc.

Officer
BridgeBio Pharma, Inc. logo
BBIO

BridgeBio Pharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (34 total)

  • Faeth Therapeutics, Inc. logo
    FTH

    Faeth Therapeutics, Inc.

    Jul 1, 2026
    Purchase
    Indirect
    4.4K shares at avg. $23.40$103K
  • Faeth Therapeutics, Inc. logo
    FTH

    Faeth Therapeutics, Inc.

    Jul 1, 2026
    Purchase
    Indirect
    600 shares at avg. $24.22$15K
  • Faeth Therapeutics, Inc. logo
    FTH

    Faeth Therapeutics, Inc.

    Jun 30, 2026
    Purchase
    Indirect
    1.9K shares at avg. $22.95$44K
  • Faeth Therapeutics, Inc. logo
    FTH

    Faeth Therapeutics, Inc.

    Jun 30, 2026
    Purchase
    Indirect
    1.6K shares at avg. $23.88$39K
  • Faeth Therapeutics, Inc. logo
    FTH

    Faeth Therapeutics, Inc.

    Jun 30, 2026
    Purchase
    Indirect
    4.3K shares at avg. $24.98$106K
  • Faeth Therapeutics, Inc. logo
    FTH

    Faeth Therapeutics, Inc.

    Jun 29, 2026
    Purchase
    Indirect
    831 shares at avg. $23.34$19K
  • Faeth Therapeutics, Inc. logo
    FTH

    Faeth Therapeutics, Inc.

    Jun 26, 2026
    Purchase
    Indirect
    4.2K shares at avg. $24.90$105K
  • Faeth Therapeutics, Inc. logo
    FTH

    Faeth Therapeutics, Inc.

    Jun 26, 2026
    Purchase
    Indirect
    1.4K shares at avg. $25.55$35K
  • Faeth Therapeutics, Inc. logo
    FTH

    Faeth Therapeutics, Inc.

    Jun 26, 2026
    Purchase
    Indirect
    100 shares at avg. $26.39$3K
  • Faeth Therapeutics, Inc. logo
    FTH

    Faeth Therapeutics, Inc.

    Jun 26, 2026
    Purchase
    Indirect
    580 shares at avg. $23.61$14K

1-10 of 34